Sound Income Strategies’s Ionis Pharmaceuticals IONS Stock Holding History

Sound Income Strategies’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300	Closed	-$22.5K	–	1411
2026 Q1	$22.5K	Buy	300 +14	+5%	+$1.1K	﹤0.01%	1133
2025 Q4	$21.8K	Buy	+286	New	+$21.5K	﹤0.01%	1115
2022 Q1	–	Sell	-20	Closed	-$1K	–	903
2021 Q4	$1K	Hold	20	–	–	﹤0.01%	779
2021 Q3	$1K	Hold	20	–	–	﹤0.01%	753
2021 Q2	$1K	Buy	+20	New	+$783	﹤0.01%	791
2021 Q1	–	Sell	-20	Closed	-$1K	–	1005
2020 Q4	$1K	Hold	20	–	–	﹤0.01%	787
2020 Q3	$1K	Hold	20	–	–	﹤0.01%	745
2020 Q2	$1K	Hold	20	–	–	﹤0.01%	704
2020 Q1	$1K	Buy	+20	New	+$1.11K	﹤0.01%	667

Other funds holding IONS

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Sound Income Strategies's IONS Position: Q2 2026 in Review

Sound Income Strategies sold out of Ionis Pharmaceuticals (IONS) in Q2 2026, closing a stake of 300 shares — an estimated $22.5K sold.

Sound Income Strategies first reported a position in IONS in Q1 2020 and held it in 9 quarters. The position peaked at $22.5K in Q1 2026. 318 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Sound Income Strategies reported no remaining Ionis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sound Income Strategies sold 300 Ionis Pharmaceuticals shares in Q2 2026, an estimated $22.5K.
Sound Income Strategies first reported a position in Ionis Pharmaceuticals in Q1 2020 and held it in 9 quarters.
Sound Income Strategies's Ionis Pharmaceuticals position peaked at $22.5K in Q1 2026.
318 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.